Le Lézard
Classified in: Health, Science and technology

Worldwide Microcarrier Industry to 2027 - Featuring General Electric, Eppendorf and Thermo Fisher Scientific Among Others - ResearchAndMarkets.com


The "Global Microcarrier Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast" report has been added to ResearchAndMarkets.com's offering.

The global microcarrier market was valued at USD 1,271.04 Million in 2019 and is projected to reach USD 1,906.98 Million by 2027, growing at a CAGR of 5.52% from 2020 to 2027.

The Global Microcarrier Market report provides a holistic evaluation of the market for the forecast period. The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Microcarrier Market study provides an outlook on the development of market in terms of revenue throughout the prognosis period.

The increasing prevalence of cancer cases is playing a major role in the growth of the Microcarrier Market. In addition, the growing demand for cell based vaccines is fueling the growth of the market over the forecast period. However, high cost of cell biology research and unavailability of inexpensive serum free media are some of the factor likely to hamper the growth of the market.

This report provides an all-inclusive environment of the analysis for the Global Microcarrier Market. The market estimates provided in the report are the result of in-depth secondary research, primary interviews and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics

Along with the market overview, which comprises of the market dynamics the chapter includes a Porter's Five Forces analysis which explains the five forces: namely buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in the Global Microcarrier Market. It explains the various participants, such as system integrators, intermediaries and end-users within the ecosystem of the market. The report also focuses on the competitive landscape of the Global Microcarrier Market.

Market Dynamics

Drivers

Restraint

Opportunities

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/srugl0


These press releases may also interest you

at 09:10
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
StatLab Medical Products ("StatLab"), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory ("SDL"), a Chicago-based manufacturer of printed diagnostic...

at 09:10
DIC Algae Oil Sulfurized Extreme Pressure Additives Present Promising Alternatives to Lard Oils and Vegetable Oils in Lubricating Oils, Metalworking Fluids, and Greases
Global metalworking fluid, grease, and lubricating oil manufacturers, notably those seeking new, more sustainable lubricants using renewable base oils/high-quality additives for the automotive and electric vehicle (EV) industries, can anticipate new...

at 09:05
LumaBridge Appoints Todd Lehman as Chief Executive Officer
LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Chief Executive Officer, President and member...

at 09:05
Ontada Names Jade Cusick Chief Commercial Officer
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Jade Cusick as its new Chief Commercial Officer and member of the Ontada leadership...

at 09:05
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to patients suffering from devastating autoimmune diseases and cancers, today announced the...

at 09:05
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and...

More news about Health...


News published on and distributed by: